Evolution characteristics of dynamic balance disorder over the course of PD and relationship with dopamine depletion

Objective This study aimed to assess the evolution of dynamic balance impairment during the course of Parkinson's disease (PD) and to clarify the contribution of striatal dopaminergic innervation to poor dynamic balance. Methods In our study, 89 patients with PD (divided into 2 groups according to the H-Y stage) and 39 controls were included. Kinematic data were recorded by a portable inertial measurement unit system. Dopaminergic loss in the striatal subregion was verified through the 11C-CFT PET examination. The severity of white matter hyperintensities (WMHs) was assessed by the Scheltens scale. The correlation between dynamic kinematic parameters and dopamine transporter availability was analyzed by multivariate regression analysis. Results Patients with early PD presented with imbalance featured by smaller three-dimensional trunk ROM with reduced trunk coronal angular velocity during walking and with reduced trunk sagittal angular velocity during the stand-to-sit task (all p < 0.05). These abnormalities were not more severe at a later stage. The ROM in the coronal and transverse planes during walking correlated with caudate DAT uptake (β = 0.832, p = 0.006, Q = 0.030, and β = 0.890, p = 0.003, Q = 0.030) after controlling for age, gender, and WMHs. As the disease progressed, the trunk sagittal and transverse angular velocities during walking and trunk sagittal angular velocity when turning and sitting-to-standing were slower, which was accompanied by reduced gait velocity gradually (all p < 0.05). These parameters related to disease progression have no association with striatal DAT uptake (all p > 0.05). Conclusion The dynamic balance in PD was impaired from the early stages, and the characteristics of the impairment changed differently as the disease progressed. Dopaminergic denervation has a lower contribution to dynamic balance disorders throughout PD.

[1]  Z. Prete,et al.  Early balance impairment in Parkinson’s Disease: Evidence from Robot-assisted axial rotations , 2021, Clinical Neurophysiology.

[2]  Y. Sohn,et al.  White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease , 2021, Movement disorders : official journal of the Movement Disorder Society.

[3]  C. Lustig,et al.  α4β2* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders , 2020, Annals of neurology.

[4]  K. Mombaur,et al.  Slow but Steady: Similar Sit-to-Stand Balance at Seat-Off in Older vs. Younger Adults , 2020, Frontiers in Sports and Active Living.

[5]  B. Galna,et al.  Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology , 2020, Frontiers in Aging Neuroscience.

[6]  C. Hurt,et al.  Dopamine-mediated improvements in dynamic balance control in Parkinson's disease. , 2020, Gait & posture.

[7]  Xiang-Zhen Yuan,et al.  Transverse Strips Instead of Wearable Laser Lights Alleviate the Sequence Effect Toward a Destination in Parkinson's Disease Patients With Freezing of Gait , 2020, Frontiers in Neurology.

[8]  Jungsu S. Oh,et al.  Areas of white matter hyperintensities and motor symptoms of Parkinson disease , 2020, Neurology.

[9]  Roberto Cano-de la Cuerda,et al.  Trunk Range of Motion Is Related to Axial Rigidity, Functional Mobility and Quality of Life in Parkinson’s Disease: An Exploratory Study , 2020, Sensors.

[10]  N. Mikuni,et al.  Neuroimaging and neurophysiological evaluation of severity of Parkinson’s disease , 2020, Journal of Clinical Neuroscience.

[11]  Martina Mancini,et al.  Speeding Up Gait in Parkinson's Disease. , 2020, Journal of Parkinson's disease.

[12]  Douglas N. Martini,et al.  Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease. , 2019, Parkinsonism & related disorders.

[13]  A. Pagnussat,et al.  Is the dopaminergic loss associated with gait and postural impairments in subjects with Parkinson's disease at different motor stages? , 2019, The European journal of neuroscience.

[14]  Paolo Bonato,et al.  Gait impairments in Parkinson's disease , 2019, The Lancet Neurology.

[15]  Douglas N. Martini,et al.  Overview of the cholinergic contribution to gait, balance and falls in Parkinson's disease. , 2019, Parkinsonism & related disorders.

[16]  A. Pagnussat,et al.  Impairments in gait kinematics and postural control may not correlate with dopamine transporter depletion in individuals with mild to moderate Parkinson's disease , 2019, The European journal of neuroscience.

[17]  D. Brooks,et al.  Clinical implications of early caudate dysfunction in Parkinson’s disease , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  J. Gan,et al.  Exploring the association between Cerebral small‐vessel diseases and motor symptoms in Parkinson's disease , 2019, Brain and behavior.

[19]  Tarique Siragy,et al.  Quantifying Dynamic Balance in Young, Elderly and Parkinson's Individuals: A Systematic Review , 2018, Front. Aging Neurosci..

[20]  Jordan J. Craig,et al.  Coordination of trunk and foot acceleration during gait is affected by walking velocity and fall history in elderly adults , 2018, Aging Clinical and Experimental Research.

[21]  Julie Nantel,et al.  Fallers with Parkinson's disease exhibit restrictive trunk control during walking. , 2018, Gait & posture.

[22]  Chiarella Sforza,et al.  Gait evaluation using inertial measurement units in subjects with Parkinson's disease. , 2018, Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology.

[23]  T. Vahlberg,et al.  Striatal dopamine in Parkinson disease: A meta‐analysis of imaging studies , 2017, Annals of neurology.

[24]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.

[25]  F. Horak,et al.  The quality of turning in Parkinson’s disease: a compensatory strategy to prevent postural instability? , 2016, Journal of NeuroEngineering and Rehabilitation.

[26]  M. Hallett,et al.  Motor automaticity in Parkinson's disease , 2015, Neurobiology of Disease.

[27]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[28]  P. Silburn,et al.  Wearable Sensor Use for Assessing Standing Balance and Walking Stability in People with Parkinson’s Disease: A Systematic Review , 2015, PloS one.

[29]  E. Hirsch,et al.  Gait Disorders in Parkinsonian Monkeys with Pedunculopontine Nucleus Lesions: A Tale of Two Systems , 2013, The Journal of Neuroscience.

[30]  Dae Hyuk Moon,et al.  Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy , 2012, The Journal of Nuclear Medicine.

[31]  R. Albin,et al.  Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. , 2011, Brain : a journal of neurology.

[32]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[33]  S. Lehéricy,et al.  Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. , 2010, The Journal of clinical investigation.

[34]  M. Grabiner,et al.  Variation in trunk kinematics influences variation in step width during treadmill walking by older and younger adults. , 2010, Gait & posture.

[35]  Kamiar Aminian,et al.  The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[36]  Jeffrey M. Hausdorff,et al.  Fluctuation and synchronization of gait intervals and gait force profiles distinguish stages of Parkinson's disease. , 2007, Physica A.

[37]  Bastiaan R. Bloem,et al.  Quantification of trunk rotations during turning and walking in Parkinson’s disease , 2007, Clinical Neurophysiology.

[38]  Zhenxin Zhang,et al.  Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai , 2005, The Lancet.

[39]  C. Hui-Chan,et al.  Switching of movement direction is central to parkinsonian bradykinesia in sit‐to‐stand , 2002, Movement disorders : official journal of the Movement Disorder Society.

[40]  E. Yoshikawa,et al.  Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. , 2001, Brain : a journal of neurology.

[41]  P. Scheltens,et al.  A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging , 1993, Journal of the Neurological Sciences.